<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifty three (45 males, 8 females) patients with primary meylodysplastic syndrome were seen between January 1990 and June, 1996 </plain></SENT>
<SENT sid="1" pm="."><plain>Fifteen (28%) patients had refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), 9 (17%) refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ring sideroblast (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), 21 (40%) refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), 5 (9%) refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts in transformation (REABt) and 3 (6%) had <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The mean age for the whole cohort was 59 years </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and RAEBt were significantly younger than other FAB types with a mean age of 53.5 and 45 years respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Among the FAB types <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> appeared to be over represented </plain></SENT>
<SENT sid="5" pm="."><plain>Symptomatic <z:hpo ids='HP_0001903'>anaemia</z:hpo> (66% cases) was the major cause to seek medical attention </plain></SENT>
<SENT sid="6" pm="."><plain>The commonest laboratory findings was <z:hpo ids='HP_0001903'>anaemia</z:hpo>; Hb &lt; 8 g/dl in 31 (59%) patients </plain></SENT>
<SENT sid="7" pm="."><plain>Only two patients had Hb &gt; 12 g/dl at presentation </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty four (45%) patients had normocytic <z:hpo ids='HP_0001903'>anaemia</z:hpo>, mainly in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> group (61%) </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0000248'>Macrocytosis</z:mp> was a dominant finding in patients with RA (53%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (53%) </plain></SENT>
<SENT sid="10" pm="."><plain>Bicytopenia (72%) was a more common finding than <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> (8%) </plain></SENT>
<SENT sid="11" pm="."><plain>Bone marrow was normocellular in 32 (60%) patients and hypoplastic in 11 (21%) </plain></SENT>
<SENT sid="12" pm="."><plain>Dyserythropoiesis predominantly affected RA (80%), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (55%) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> (43%) groups </plain></SENT>
<SENT sid="13" pm="."><plain>Bilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (21%) was commoner than trilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (19%) </plain></SENT>
<SENT sid="14" pm="."><plain>Increased bone marrow <z:mp ids='MP_0003045'>fibrosis</z:mp> was seen in about half of the available trephines, mainly in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> patients </plain></SENT>
<SENT sid="15" pm="."><plain>Median survival of patients was ten months with a follow up duration of 2-55 months </plain></SENT>
<SENT sid="16" pm="."><plain>Four patients transformed to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (M1 or M2) and died subsequently </plain></SENT>
<SENT sid="17" pm="."><plain>However, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was major complication and cause of <z:hpo ids='HP_0011420'>death</z:hpo> (10 cases) </plain></SENT>
<SENT sid="18" pm="."><plain>The preponderance of younger people to acquire the disease (especially the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and RAEBt variants), the emergence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> as the major group of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and increased prevalence of hypoplastic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> point towards non-therapeutic <z:chebi fb="0" ids="50902">genotoxin</z:chebi> (s) in the causation of disease </plain></SENT>
<SENT sid="19" pm="."><plain>Shortened survival and low rate of <z:hpo ids='HP_0011009'>acute</z:hpo> transformation points that patients did not withstand cytopenias and died earlier </plain></SENT>
</text></document>